ONCE its acquisition of Healthnotes is finalised, listed medication adherence company MedAdvisor says it expects to reach more than $160 million in annual value of prescription orders.
According to an ASX update issued yesterday, the company's 'Tap to Refill' function is performing strongly, and has now processed more than 2 million script orders.
Tap to Refill allows patients to order prescription repeats to be dispensed in advance at their pharmacy, and is currently being used by about 40% of MedAdvisor's 230,000 strong user base.
MedAdvisor ceo Robert Read said the feature is also now being used by diabetes patients and their carers to reserve their National Diabetes Services Scheme products remotely.
Read said the $5.5 million addition of Healthnotes, which was overwhelmingly approved by MedAdvisor shareholders at an extraordinary general meeting this week, will give the overall operation more than 500,000 users.
MedAdvisor also this week announced the appointment of Simon Chamberlain to the newly created role of General Manager of Product & Strategy.
Chamberlain joins MedAdvisor with experience in scaling up businesses, with his most recent role being at health insurer Medibank and previous senior executive positions with Qantas' digital booking startup Hooroo, web analytics provider Hitwise and consumer insights firm Experian.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Oct 16
